Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2007 Jul 19;357(3):296-8.
doi: 10.1056/NEJMe078111.

Anti-TNF antibodies for Crohn's disease--in pursuit of the perfect clinical trial

James D Lewis
Editorial

Anti-TNF antibodies for Crohn's disease--in pursuit of the perfect clinical trial

James D Lewis. N Engl J Med. .
No abstract available

PubMed Disclaimer

Comment in

  • Anti-TNF antibodies for Crohn's disease.
    Camilleri M. Camilleri M. N Engl J Med. 2007 Oct 18;357(16):1662; author reply 1662. doi: 10.1056/NEJMc072381. N Engl J Med. 2007. PMID: 17942882 No abstract available.

Comment on

  • Certolizumab pegol for the treatment of Crohn's disease.
    Sandborn WJ, Feagan BG, Stoinov S, Honiball PJ, Rutgeerts P, Mason D, Bloomfield R, Schreiber S; PRECISE 1 Study Investigators. Sandborn WJ, et al. N Engl J Med. 2007 Jul 19;357(3):228-38. doi: 10.1056/NEJMoa067594. N Engl J Med. 2007. PMID: 17634458 Clinical Trial.
  • Maintenance therapy with certolizumab pegol for Crohn's disease.
    Schreiber S, Khaliq-Kareemi M, Lawrance IC, Thomsen OØ, Hanauer SB, McColm J, Bloomfield R, Sandborn WJ; PRECISE 2 Study Investigators. Schreiber S, et al. N Engl J Med. 2007 Jul 19;357(3):239-50. doi: 10.1056/NEJMoa062897. N Engl J Med. 2007. PMID: 17634459 Clinical Trial.

MeSH terms

Substances

Associated data